Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Pulmonology ; 28(5): 350-357, 2022.
Article in English | MEDLINE | ID: mdl-32513638

ABSTRACT

INTRODUCTION: There are scarce data on the routine latent tuberculosis infection treatment (LTBIT) and factors associated with a non-completion in high tuberculosis burden countries. Therefore, in this study we aimed to evaluate the factors associated with non-completion of LTBIT. MATERIALS AND METHODS: This was a non-matched case control study conducted at a University Hospital in Rio de Janeiro, Brazil. A total of 114 cases and 404 controls were enrolled between January/1999 and December/2009. Cases were close contacts who did not complete the LTBIT and controls were the contacts that completed it. Multivariate analysis was used to investigate risk factors associated with non-completion of LTBIT among contacts in two different periods of recruitment. RESULTS: Factors associated with non-completion LTBIT included: drug use (OR 23.33, 95% CI 1.83-296.1), TB treatment default by the index case (OR 16.97, 95% CI 3.63-79.24) and drug intolerance. TB disease rates after two years of follow up varied from 0.4% to 1.9%. The number necessary to treat to prevent one TB case among contacts was 116. CONCLUSIONS: Non-completion treatment by the index case and illicit drug use were associated with not completing latent tuberculosis infection treatment and no tuberculosis disease was identified among those who completed latent tuberculosis infection treatment.


Subject(s)
Latent Tuberculosis , Tuberculosis , Brazil/epidemiology , Case-Control Studies , Humans , Latent Tuberculosis/drug therapy , Latent Tuberculosis/epidemiology , Risk Factors
2.
Am J Transplant ; 13(12): 3230-5, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24119248

ABSTRACT

This retrospective cohort study assessed the results of the implementation of preventive recommendations for tuberculosis (TB) among renal transplant recipients in an endemic area (Rio de Janeiro, Brazil). Subjects were defined as at high risk for TB if they had latent tuberculosis infection (LTBI), reported recent close contact with individuals with TB or received a graft from a donor with LTBI. A 6-month course of isoniazid preventive therapy (IPT) was targeted to high-risk subjects. The study end point was TB confirmed by culture. Altogether, 535 patients were included. Median follow-up was 59 months. The overall cumulative incidence of TB was 2.1% while among the 274 patients in whom the preventive protocol was fully implemented, the incidence was only 0.7%. The incidence of TB among 75 high-risk recipients not treated with isoniazid (7%) was significantly higher than that observed in 209 untreated low-risk patients (1%, p = 0.006) and in 65 high-risk subjects that received IPT (no case, p = 0.03). In conclusion, the implementation of preventive recommendations for TB in an endemic area allowed the appropriate discrimination between high- and low-risk renal transplant recipients and was associated with long-term reduction in the incidence of this complication among high-risk subjects.


Subject(s)
Kidney Transplantation , Renal Insufficiency/complications , Tuberculosis/prevention & control , Adult , Antitubercular Agents/therapeutic use , Brazil , Female , Follow-Up Studies , Humans , Incidence , Isoniazid/therapeutic use , Male , Middle Aged , Outcome Assessment, Health Care , Program Evaluation , Proportional Hazards Models , Renal Insufficiency/therapy , Retrospective Studies , Risk
3.
Vet Microbiol ; 105(1): 29-36, 2005 Jan 05.
Article in English | MEDLINE | ID: mdl-15607081

ABSTRACT

In order to determine the occurrence, serotypes and virulence markers of Shiga toxin-producing Escherichia coli (STEC) strains, 153 fecal samples of cattle randomly selected from six dairy farms in Sao Paulo State, Brazil, were examined for Shiga toxin (Stx) production by the Vero cell assay. Feces were directly streaked onto MacConkey Sorbitol Agar and incubated at 37 degrees C overnight. Sorbitol-negative colonies (maximum 20) and up to 10 sorbitol-positive colonies from each plate were subcultured onto presumptive diagnostic medium IAL. Sorbitol-negative isolates were screened with O157 antiserum for identification of O157:H7 E. coli. Isolates presenting cytotoxic activity were submitted to colony hybridization assays with specific DNA probes for stx1, stx2, eae, Ehly and astA genes. The isolation rate of STEC ranged from 3.8 to 84.6% depending on the farm analysed. STEC was identified in 25.5% of the animals, and most of them (64.1%) carried a single STEC serotype. A total of 202 STEC isolates were recovered from the animals, and except for the 2 O157:H7 isolates all the others expressed cytotoxic activity. The great majority of the STEC isolates carried both stx1 and stx2 genes (114/202, 56.4%) or stx2 (82/202, 40.6%); and whereas the Ehly sequence occurred in most of them (88%) eae was only observed in O157:H7 and O111:HNM isolates. Serotypes O113:H21, O178:H19 and O79:H14 were the most frequent STEC serotypes identified and widely distributed among animals from different farms, while others such as O77:H18, O88:H25 and O98:H17 occurred only in particular farms. This is the first report on the occurrence of STEC in dairy cattle in Sao Paulo State, and the results point to substantial differences in rate of isolation, serotypes and genetic profile of STEC that has been previously described among beef cattle in our community. Moreover, to our knowledge O79:H14 and O98:H17 represent new STEC serotypes, while O178:H19 has only been recently reported in Spain.


Subject(s)
Cattle Diseases/microbiology , Escherichia coli Infections/veterinary , Escherichia coli O157/classification , Shiga Toxin 1/biosynthesis , Shiga Toxin 2/biosynthesis , Adhesins, Bacterial/genetics , Adhesins, Bacterial/metabolism , Animals , Bacterial Toxins/genetics , Bacterial Toxins/metabolism , Brazil , Cattle , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Dairying , Escherichia coli Infections/microbiology , Escherichia coli O157/genetics , Escherichia coli O157/growth & development , Escherichia coli O157/pathogenicity , Escherichia coli Proteins/genetics , Escherichia coli Proteins/metabolism , Feces/microbiology , Female , Nucleic Acid Hybridization , O Antigens/metabolism , Serotyping , Shiga Toxin 1/genetics , Shiga Toxin 2/genetics
4.
J Infect ; 48(2): 161-7, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14720492

ABSTRACT

The frequency of diarrhoeagenic Escherichia coli (DEC) strains was investigated in 253 children up to 3 years old, with (patient group, PG, 199 children) and without (control group, CG, 54 children) diarrhoea, living in Rio de Janeiro, Brazil. DEC strains were detected in 70 (27.6%) children, including 54 (27.1%) with diarrhoea and 16 (29.6%) without diarrhoea. Enteroaggregative E. coli (EAEC) was the most frequent DEC category, accounting for 14.6% of the isolates in the PG and for 11.1% in the CG. E. coli strains carrying enteropathogenic E. coli (EPEC) virulence markers showed higher incidence in the CG (12.9%) than in the PG (8.0%). E. coli strains belonging to non-classical EPEC groups that carried eae only or eae and bfpA, designated as attaching-effacing E. coli (AEEC) were the most frequent (79.1%). Simultaneous presence of multiple EPEC virulence factors (EAF/eae/bfpA) were only detected among strains isolated from the PG. Enterotoxigenic E. coli (ETEC) strains were isolated from 5.5% of the children in the CG and from 3.5% of those in the PG. Most of the ETEC isolates were LT-probe positive (70%) and none carried both LT-I and ST-I probe sequences. One enteroinvasive E. coli (EIEC) strain was recovered from a child with diarrhoea. No stx-probe positive E. coli strains were detected. Overall, DEC strains were not found to be significantly associated with diarrhoea (p>0.05). However, the higher incidence of EAEC, the most frequent DEC category, among children with diarrhoea, suggests a potential role of EAEC as an important enteric pathogen in the community investigated.


Subject(s)
Diarrhea/microbiology , Escherichia coli Infections/microbiology , Escherichia coli/classification , Agglutination Tests , Bacterial Toxins/genetics , Bacterial Toxins/isolation & purification , Brazil/epidemiology , Child, Preschool , DNA, Bacterial/chemistry , DNA, Bacterial/genetics , Diarrhea/epidemiology , Enterotoxins/genetics , Enterotoxins/isolation & purification , Escherichia coli/genetics , Escherichia coli/isolation & purification , Escherichia coli/pathogenicity , Escherichia coli Infections/epidemiology , Feces/microbiology , Female , Humans , Incidence , Infant , Male , Nucleic Acid Hybridization , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL